drug metabolism Flashcards
processes that prevent continuous drug action
Elimination/ excretion
Metabolism- important for termination of drug action (for many drugs the metabolites are more easily excreted from the body, they are usually more polar and hydrophilic than the parent drug), metabolism of a drug can inactivate it, or it can activate a prodrug
Drug drug interactions
often due to drug metabolism issues, the more drugs you administer the more likely the adver reactions are
Phase 1 and phase 2 enzymes
Phase 1: oxidation, reduction, dealkylation, or hydrolysis; they typically introduce or reveal a functional group
Phase 2: conjugation of a drug/metabolite to an endogenous substrate molecule
localization of drug metabolizing enzymes
Organ distribution: portals of entry and exit, liver (highest overall), GI tract, all tissues have some, varies significantly for specific enzymes
Subcellular distribution: Phase 1 enzymes typically in SER, phase 2 enzymes (most are cytosolic)
1st pass effect
for orally administered drugs, following absorption from GI tract, the portal venous system transports them to the liver, significant drug metabolism can occur before reaching the general circulation (hepatic/intestinal)
Significance: can greatly lower the oral bioavailability of a drug, drugs with a large 1st pass effect need higher oral doses
phase 1 reactions enzymes
CYP450s, flavin containing monooxygneases
What do you need for CYP 450 reactions
heme, O2, NADPH reductase, single isoform of P450 reductase in all cell types
Many different isoforms of cytochrome p450, with a molecular ratio of 10-20 p450s per p450 reductase
human cyp450s
18 families but 3 main ones involved in drug metabolism (CYP1, CYP2, CYP3) with 15 human genes, with individual differences in isoform expression and catalytic activity…can result in large differences in drug metabolism
CYP3A: 50%
CYP2D6: 25%
CYP2C9: 15 %
BUT relative CYP isoform content doesnt = significance in drug metabolism
lots of CYPs are expressed in high levels even tho 3A, 2D6, and 2C9 are the major metabolizers of most drugs
Flavin-containing monooxygenases
MOO reactions: substrates have soft nucleophiles, exclude non substrates
with a broad substrate profile than P450s, even broader substrate profile than p450s
products are usually more polar and less toxic
Use NADPH and FADH
FMO3 mainly in liver
Phase 2 reactions
gsh conjugation sulfation acetyl ations
Broad substrate specificities, some are inducible, Vmax affected by conventional kinetics and finite supply of conjugant molecules
possible order and cooperativity of phase 1 and 2 enzymes
drug-> phase 1 -> excretion
drug -> phase 1 -> phase 2 -> excretion
drug -> phase 2 -> excretion
drug-> phase 2 -> phase 1 -> excretion
phase 2 reactions, conjugation capacity, and abundance of raw materials for conjugation
Glucuronidation: high capacity, high abundance
Sulfation: low capacity, low abundance
Glutathione conjugation: low capacity, low abundance
Acetylation: variable capacity, variable abundance
enzyme induction
exposure to some drugs and environmental chemical markedly up regulates drug metabolizing enzyme amount and or activity (usually due up regulation of transcription
more enzyme= faster metabolism
ethanol induces CYP 2E1
CYP2D6 is not very inducible
a single inducer can affect many drugs handled by that enzyme
induction can increase or decrease drug effects depending on whether metabolite is active or inactive
Decreased effectiveness, or increased effects/toxicity
Enzyme induction can take 1-2 days, and takes days to weeks to return to non induced levels once inducer is removed
not all inducers work as fast
CYP 2D6
Not very abundant (1.5% of total CYP450 content)
handles 25% of all drugs
not very inducible
makes it very susceptible to competitive inhibition
does an inducer have to be a substrate
not all substrates are inducers, some inducers are substrates and some are not